Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty - a Randomized, Two by Two Factorial, Double-blind, Placebo-controlled Clinical Trial

NCT06234631 is registered in ClinicalTrials.gov with Chad Brummett as lead sponsor.

NCT NCT06234631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06234631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty - a Randomized, Two by Two Factorial, Double-blind, Placebo-controlled Clinical Trial
Lead sponsor
Chad Brummett
Phase
Phase 2
Overall status
Recruiting
Start date
March 13, 2024
Completion date
January 31, 2029
Enrollment
380 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

knee replacement surgery, osteoarthritis, knee